BioPharma Credit PLC (FRA:B3P)

Market Cap	940.96M +5.3%
Revenue (ttm)	115.01M -15.0%
Net Income	94.09M -12.7%
EPS	0.08 -9.1%
Shares Out	n/a
PE Ratio	10.29
Forward PE	n/a
Dividend	0.07 (8.45%)
Ex-Dividend Date	Oct 8, 2026

Volume	n/a
Open	0.8650
Previous Close	0.8900
Day's Range	0.8650 - 0.8650
52-Week Range	0.7550 - 0.9000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 24, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

• Industry: Asset Management
• Sector: Financials
• Founded: 2016
• Country: United Kingdom
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: B3P

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 12, 2026

Data Sources Report a data error